RF Acquisition Corp. (RFACU) Prices $100M IPO

IPO-Pricing
Ligand-Logo

Avista Public Acquisition Corp. II (AHPA) to Combine with Ligand Pharmaceuticals

Avista Public Acquisition Corp. II (NASDAQ:AHPA) has entered into a definitive agreement to acquire Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) to spin-off its antibody discovery business OmniAb, Inc. at a pre-money equity valuation of $850 million. The San-Diego based biopharmaceutical company is focused on developing technologies that help pharmaceutical companies discover medicine. Ligand’s OmniAb platform provides
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
energy space thumbnail

Space De-SPACS Deliver Mixed Performance, But Are Worth Watching in Earnings Season

As SPACs rode a wave of popular EV deals, it appeared that the sky was the limit for the asset class. That was, of course, until SPACs launched into the space sector. Since then, the sector has been a mixed bag for SPACs. At the end of 2021, before even most of the recent market
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
latest-news

Mount Rainier Acquisition Corp (RNER) to Combine with HUB Security in $1.2B Deal

Mount Rainier (NASDAQ:RNER) has entered into a definitive agreement to acquire confidential computing developer HUB Cyber Security Israel at a pro forma enterprise value of approximately $1.28 billion. The Tel Aviv-based company, founded by veterans of Israeli intelligence units, develops and markets computing solutions and services that aim to disrupt cybersecurity for enterprises and governments
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Primavera Capital (PV) to Combine with Lanvin Group in $1.5bn Deal

Primavera (NYSE:PV) has entered into a definitive agreement to combine with the luxury fashion Lanvin Group at an enterprise value of $1.5 billion, or 2.7x its 2022E sales. The Paris-based group produces luxury apparel through four signature brands with about 300 retails stores and 3,600 employees globally. The combined company is expected to trade on
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Podcasts-SI

Podcast: ZeroFox CEO James C. Foster & L&F Acquisition Corp. CEO Adam Gerchen


This week, we speak with James C. Foster, CEO of cybersecurity firm, ZeroFox.

ZeroFox entered into a $1.3 billion dollar combination agreement with L&F Acquisition Corporation in December.

We discuss how the Russia-Ukraine war has ushered in a new era for cybersecurity and what types of companies face the biggest threats in this new environment.

...READ MORE
Terran-Orbital-logo
latest-news
coincheck logo

Thunder Bridge Capital IV (THCP) to Combine with Coincheck in $1.3bn Deal

Thunder Bridge IV (NASDAQ:THCP) has entered into a definitive agreement to combine with digital asset trading platform Coincheck at a post-transaction equity value of $1.25 billion. Coincheck, which is a subsidiary of Tokyo-based Monex Group (TYO:8698), allows users to trade crypto, NFTs and other digital assets and its app was the most-downloaded among such platforms
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
latest-news

The Latest SPAC News and Rumors: March 21, 2022

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: D-Orbit announces upcoming launch, Hong Kong sees increased interest in SPACs, and Skadden hires SEC veteran who oversaw SPAC enforcement 

D-Orbit Announces Upcoming Launch of SPACELUST, its Fifth ION Satellite Carrier Mission

D-Orbit, the space logistics and orbital transportation company, announced today the upcoming launch of SPACELUST, the fifth mission using the Company’s proprietary ION Satellite Carrier (ION), a flexible and cost-effective orbital transfer vehicle (OTV) spacecraft designed both to precisely deploy satellites and perform technology demonstrations of third-party payloads in orbit.

...READ MORE
SPAC-Terms-Tracker
Starry Inc.
Alert-2
latest-news

The Latest SPAC News and Rumors: March 18, 2022

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Hydrow raises $55 million, and first Hong Kong SPAC has slow start in trading debut

Hydrow Raises $55M as the At-Home Fitness Industry Faces a Post-Lockdown Reckoning

Hydrow, maker of a $2,500 connected rowing machine, said Thursday it has landed another $55 million in funding to fuel its growth while the at-home fitness industry undergoes a shakeout as consumers return to gyms after two years of Covid-related lockdowns and restrictions.

...READ MORE
benuvia logo

Pono Capital Corp (PONO) to Combine with Benuvia in $440M Deal

Mar 18, 2022 INTEL by sam.beattie
Pono (NYSE:PONO) has entered into a definitive agreement to acquire Benuvia, Inc., a drug developer focused on pharmaceutical cannabinoids, at an enterprise value of $440 million. The Arizona-based company owns an FDA approved cannabinoid drug SYNDROS (dronabinol oral solution CII), and synthetic cannabinoid manufacturing facilities in the U.S. The combined company is expected to trade
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Vickers Vantage Corp. I (VCKA) to Combine with Scilex in $1.64B Deal

Vickers Vantage Corp. I (NASDAQ: VCKA) has entered into a definitive agreement to combine with commercial biopharmaceutical company Scilex, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), at a pro forma equity value of approximately $1.64 billion. The Palo Alto-based company focuses on the development and commercialization of non-opioid pain management products for treatment
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Brookline Capital Acquisition Corp. (BCAC) to Combine with Apexigen in $205M Deal

Brookline (NASDAQ:BCAC) has entered into a definitive agreement to combine with Apexigen at a net-equity value of $205 million. San Carlos, California-based Apexigen is developing a range of immunological cancer treatments with four currently in Phase II trials. The combined company is expected to trade on the Nasdaq under the symbol “APGN” once the deal
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.